Carcinoma of the penis pathophysiology: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{Carcinoma of the penis}} | {{Carcinoma of the penis}} | ||
'''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:mgibson@perfuse.org] Phone:617-632-7753 | '''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:mgibson@perfuse.org] Phone:617-632-7753; Joel Gelman, M.D. [mailto:jgelman@uci.edu], ''Director of the Center for Reconstructive Urology and Associate Clinical Professor in the Department of Urology at the University of California,Irvine'' | ||
==Overview== | ==Overview== | ||
== Pathology == | |||
* A. Precancerous Dermatologic Lesions | |||
* B. Carcinoma in Situ (Bowen Disease, Erythroplasia of Queyrat) | |||
* C. Invasive Carcinoma of the Penis | |||
==References== | ==References== |
Revision as of 15:48, 19 January 2012
Carcinoma of the penis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Carcinoma of the penis pathophysiology On the Web |
American Roentgen Ray Society Images of Carcinoma of the penis pathophysiology |
Risk calculators and risk factors for Carcinoma of the penis pathophysiology |
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Joel Gelman, M.D. [2], Director of the Center for Reconstructive Urology and Associate Clinical Professor in the Department of Urology at the University of California,Irvine
Overview
Pathology
- A. Precancerous Dermatologic Lesions
- B. Carcinoma in Situ (Bowen Disease, Erythroplasia of Queyrat)
- C. Invasive Carcinoma of the Penis